- Investing Ideas
- Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
AcrobiosystemsLtd
Market Cap: CN¥7.5b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥45.00
7D
-15.8%
1Y
-19.1%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.3b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
New
688443
CN¥22.63
7D
-4.9%
1Y
-34.8%